Kristine Wilhelm Schuler, Pfizer Oncology; Meera I. Kodukulla, AstraZeneca; Charles I. Rosenblum, Merck & Co., Inc; Nataline Meinhardt, Merck & Co., Inc; Rhyomi C. Sellnow, MedThink SciCom; Todd Parker, MedThink SciCom
While the demand grows to publish and present industry-sponsored research in parallel, the need for collaboration among authors, journals/publishers, and congresses has evolved. Some congress- and society-affiliated journals are soliciting manuscript submissions to coincide with congress presentations, and several journals and congresses have specific guidelines for these publications. Given that the process for simultaneous publication can present workflow challenges, this infographic highlights approaches to optimize management of the overall development timeline. Informed by guidance from publication professionals, journal editors, congress officials, and study sponsors, we spotlight strategies to achieve successful simultaneous publication and address pain points that are broadly applicable to industry-sponsored research across therapeutic areas.
22MTS0603_SimultPubs_Timeline_4-1_FINAL-1Please refer to our full publication published in Current Medical Research and Opinion (CMRO) earlier this year for additional details (available at https://www.tandfonline.com/doi/full/10.1080/03007995.2022.2078102).
Schuler KW, Kodukulla MI, Rosenblum CI, Meinhardt N, Sellnow RC, Parker T. Parallel publication of articles and congress presentations for industry-sponsored research: strategies for success. Curr Med Res Opin. 2022;38:875-880.